A Study to Assess Single and Multiple Doses of IkT-148009 in Healthy Elderly Participants and Parkinson's Patients

NCT04350177 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

101

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Elderly
Parkinson Disease

Interventions

DRUG: IkT-148009
DRUG: Placebo

Sponsor

ABLi Therapeutics, Inc.